Literature DB >> 14238600

[ON THE THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN). EXPERIENCES WITH 160 DIABETICS].

H ROBBERS, K H BRUMBY, K J TRAUMANN.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS; CLINICAL RESEARCH; DRUG THERAPY; DRUG TOLERANCE; LIVER; PATHOLOGY; PYRIMIDINES; SULFONAMIDES; TOLBUTAMIDE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14238600

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  4 in total

1.  GLYCODIAZINE IN DIABETES MELLITUS: A CLINICAL TRIAL.

Authors:  R D STEWART; D E ANDERSON
Journal:  Br Med J       Date:  1965-09-18

2.  [Influence of liver diseases and kidney function disorders and phenylbutazone, phenprocoumarol and doxycycline on the excretion of glycodiazine].

Authors:  H Held; B Kaminski; H F von Oldershausen
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

Review 3.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

4.  Glymidine.

Authors: 
Journal:  Br Med J       Date:  1967-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.